EMX Royalty (CVE:EMX) Shares Up 1.5% – Should You Buy?
EMX Royalty (CVE:EMX) Trading 1.5% Higher – Should You Buy?
Source link
Similar Posts
India set to log record FII outflows as net sale hits Rs 1.58 lakh crore in 2025
Foreign Institutional Investors (FIIs) are poised to end 2025 with a record-breaking exodus from Indian equities, marking the steepest net outflows ever seen in the country’s capital markets. As of December 27, FIIs have sold equities worth Rs 22,130 crore through the exchanges, taking the cumulative equity selling in calendar year 2025 to Rs 2,31,990…
Short Interest in Inpex Corp. (OTCMKTS:IPXHY) Decreases By 44.1%
Inpex Corp. (OTCMKTS:IPXHY – Get Free Report) saw a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 30,900 shares, adecreaseof44.1% from the July 15th total of 55,300 shares. Based on an average trading volume of 69,300 shares, the days-to-cover ratio is presently 0.4 days….
Fortis Just Might Be the Best Canadian Dividend Stock to Buy in April
As the calendar rolls over into April, many investors may be looking to rotate their portfolios into increasingly defensive stocks. Those with outsized exposure to higher growth companies may be looking to take some risk off the table. Accordingly, looking at top Canadian dividend stocks in this environment certainly makes sense, with Fortis (TSX:FTS) remaining…
Shilpa Medicare Shares Rally 3% as Arm Secures CEP for Desmopressin – Equitypandit
October 4, 2024October 4, 2024 Shares of Shilpa Medicare Ltd were trading in the green and 3% higher on 4 October after the company announced that its subsidiary, Shilpa Pharma Lifesciences Ltd has received CEP from EDQM. In its regulatory filing, the company said that Shilpa Pharma Lifesciences Limited…
